Product image of Metformin Accord (Metformin Hydrochloride) supplied by GNH India

Metformin Accord

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformin Accord (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformin Accord, is a Biguanide presented as an oral dosage form for oral use. It decreases hepatic glucose production and improves peripheral insulin sensitivity to manage type 2 diabetes mellitus in adults.

GNH India supplies Metformin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metformin Accord belongs to the biguanide class and is used to improve glycaemic control in disorders of glucose metabolism.
  • Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels.
  • Impaired glucose tolerance: reduces the risk of progression to overt diabetes.
  • Prediabetes: enhances insulin sensitivity and helps maintain normal glucose homeostasis.

How It Works

  • Metformin Hydrochloride acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis and decreases hepatic glucose output. It also increases peripheral glucose uptake by enhancing insulin‑mediated activation of AMP‑activated protein kinase (AMPK), thereby improving insulin sensitivity in muscle and adipose tissue.

Side Effects

Metformin Accord may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: frequent loose stools.
  • Abdominal discomfort: cramping or pain.
  • Metallic taste: transient after dosing.
  • Weight loss: modest reduction in body weight.
  • Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: life‑threatening metabolic acidosis.
  • Severe skin reactions: such as Stevens‑Johnson syndrome.
  • Hepatotoxicity: elevated liver enzymes.
  • Hypoglycaemia: when combined with other glucose‑lowering agents.
  • Pancreatitis: rare inflammation of the pancreas.
  • Anemia: due to reduced red blood cell production.

Precautions & Warnings

  • When prescribing Metformin Accord, clinicians should consider several safety measures.
  • Renal function monitoring: assess creatinine clearance before initiation and periodically.
  • Hepatic function assessment: avoid use in patients with significant liver disease.
  • Risk of lactic acidosis: contraindicated in conditions predisposing to hypoxia.
  • Vitamin B12 surveillance: monitor levels during long‑term therapy.
  • Avoid in severe heart failure: increased risk of metabolic complications.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformin Accord can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate lactic acidosis.
  • Cimetidine: increases metformin plasma concentrations.
  • Alcohol: enhances risk of lactic acidosis.
  • Carbamazepine: reduces metformin effectiveness.
  • Rifampicin: may lower metformin levels.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycaemia symptoms.
  • ACE inhibitors: can affect renal function, influencing metformin clearance.
  • Diuretics: may alter fluid balance and renal excretion.
  • Warfarin: potential for altered anticoagulation control.
  • Digoxin: monitor for changes in serum levels.

Frequently Asked Questions

Metformin Accord contains Metformin Hydrochloride, a biguanide oral antidiabetic medication. It is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus and may also be used to manage impaired glucose tolerance or prediabetes under medical supervision.

Metformin Hydrochloride reduces hepatic glucose production by inhibiting mitochondrial complex I and activates AMP‑activated protein kinase (AMPK). This dual action lowers liver‑derived glucose and increases peripheral insulin sensitivity, helping to normalize blood sugar levels.

The specific dose of Metformin Accord is determined by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety of Metformin Accord in pregnancy or while breastfeeding has not been definitively established. Healthcare providers weigh potential benefits against possible risks and may consider alternative therapies if concerns arise.

To order Metformin Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin Accord belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors in its mechanism of reducing hepatic glucose output and enhancing insulin sensitivity. It is often first‑line therapy because of its efficacy, low risk of hypoglycaemia and favourable impact on weight.

Metformin Accord should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain potency throughout its shelf life.

Metformin Accord is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablet (or other oral form) should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or hypoxia. Other serious concerns include severe skin reactions and significant vitamin B12 deficiency with long‑term use.

Metformin Accord is contraindicated in individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, and in patients with conditions that predispose to hypoxia such as severe heart failure or recent myocardial infarction.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT